Results 81 to 90 of about 584 (117)

CD8⁺ T cell responses recognizing immunodominant <i>Chlamydia</i> antigens fail to protect against infection. [PDF]

iScience
Guleed S, Nguyen NDNT, Subratheepam S, Melchiors KM, Olsen AW, Ciancaglini M, Kastner AL, Nolfi E, Pinschewer D, Follmann F, Christensen JP, Sijts A, Dietrich J.   +12 more
europepmc   +1 more source

Enhancing TB Vaccine Efficacy: Current Progress on Vaccines, Adjuvants and Immunization Strategies. [PDF]

Vaccines (Basel), 2023
Wang H, Wang S, Fang R, Li X, Xing J, Li Z, Song N.   +6 more
europepmc   +1 more source

Conserved multiepitope vaccine constructs: A potent HIV-1 therapeutic vaccine in clinical trials. [PDF]

Braz J Infect Dis, 2023
Akbari E, Seyedinkhorasani M, Bolhassani A.   +2 more
europepmc   +1 more source

Advances in vaccine adjuvant development and future perspectives. [PDF]

Drug Deliv
Sinani G, Şenel S.
europepmc   +1 more source

Chikungunya in 2025: Comprehensive Insights into Virology, Diagnostics, Vaccines, and Antiviral Therapies. [PDF]

Viruses
Zheng Z, Ji H, Shan Z, Xu J, Li J, Zhang X, Zheng J, Jiang S, Zhang N.   +8 more
europepmc   +1 more source

Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses. [PDF]

NPJ Vaccines
Rungelrath V, Ahmed M, Hicks L, Miller SM, Ryter KT, Montgomery K, Ettenger G, Riffey A, Abdelwahab WM, Khader SA, Evans JT.   +10 more
europepmc   +1 more source

Melioidosis vaccines: recent advances and future directions. [PDF]

Front Immunol
Sengyee S, Weiby SB, Rok IT, Burtnick MN, Brett PJ.   +4 more
europepmc   +1 more source

Neutralizing Antibody Responses to Chlamydia trachomatis in Women and Associations With Chlamydia Outcomes. [PDF]

J Infect Dis
Yu H, Geisler WM, Dai C, Gupta K, Cutter G, Brunham RC.   +5 more
europepmc   +1 more source

Influenza Vaccines: Current Status, Adjuvant Strategies, and Efficacy. [PDF]

Vaccines (Basel)
Mokalla VR, Gundarapu S, Kaushik RS, Rajput M, Tummala H.   +4 more
europepmc   +1 more source

Tracking Canada's 2015 vaccine research and development priorities: Where are we a decade later? [PDF]

Can Commun Dis Rep
Moqueet N, Lago K, Cortés-Kaplan S, Birdi H, Desai S, Gauhar A, Warshawsky B, Tunis M, Wilkinson K.   +8 more
europepmc   +1 more source